By Sheeba M. | June 3, 2026

Cannabis Retail Earnings Rebound in Q2 2026

TL;DR: Margin compression eases as supply stabilizes. Trulieve and Curaleaf guidance suggests 8-12% EBITDA growth ahead.

The cannabis retail sector is finally breaking out of its margin squeeze. After months of oversupply and price compression in key markets, Q2 2026 earnings season is showing real recovery signals—and that’s shifting sentiment on the largest retailers.

Trulieve‘s latest earnings call revealed Florida same-store sales growth turning positive for the first time since Q4 2025. Meanwhile, Curaleaf reported better-than-expected inventory turnover, indicating retail discipline is finally working.

What Changed?

Three factors are colliding in retailers’ favor:

The Outlook

Guidance for Q3-Q4 2026 is cautiously optimistic. Cresco Labs expects mid-single-digit revenue growth with expanding EBITDA margins. If federal policy moves on de-scheduling before year-end, institutional capital could flood back into the sector—driving a significant revaluation.

Sources

Track cannabis stocks with the Weedstock Real-Time Tracker

Leave a Reply

📅 Yesterday's News & Older Articles →